Hectorol doxercalciferol: Phase III data

Pooled 24-week data from 2 double-blind, U.S. Phase III trials in 55 patients

Read the full 130 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE